Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02416011 · ClinicalTrials.gov registry record · NA
Smoking Cessation Self-Help for Dual Users of Tobacco Cigarettes and E-Cigarettes
A NA study, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 2,896
- Enrollment target
NCT02416011: Completed NA study, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
NCT02416011 is a NA study that has completed, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 2,896 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (106% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02416011, a NA study, has completed, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,896 participants
- Enrollment target
Study Summary
The purpose of this study is to develop and test a series of booklets designed to assist smokers of tobacco cigarettes who are also using e-cigarettes (dual users) in quitting smoking and remaining smoke-free.
Primary Outcome
Percentage rate of smoking abstinence for participants who received If You Vape booklets, compared to: A) participants in an assessment-only condition; B) participants in a generic self-help condition comprising existing smoking cessation booklets.
Interventions
- BEHAVIORAL GENERIC
- BEHAVIORAL eTARGET
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,896 participants |
| Start Date | 2015-03-31 |
| Est. Completion | 2019-06-30 |
| Phase | NA |
What the finished NCT02416011 record still lists
NCT02416011 is an interventional study that assigns participants to a tested intervention. Its 2,896 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (106% higher).
The record links to 0 conditions, and to 2 interventions - of which GENERIC is the first listed.
NCT02416011 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02416011 about?
NCT02416011 is a clinical study titled "Smoking Cessation Self-Help for Dual Users of Tobacco Cigarettes and E-Cigarettes". The purpose of this study is to develop and test a series of booklets designed to assist smokers of tobacco cigarettes who are also using e-cigarettes (dual users) in quitting smoking and remaining smoke-free.
What is the current status of trial NCT02416011?
This trial is currently completed. It is a NA study. The enrollment target is 2,896 participants. The study started on 2015-03-31. Estimated completion is 2019-06-30.
What interventions are being tested in trial NCT02416011?
The interventions under investigation include: GENERIC (BEHAVIORAL), eTARGET (BEHAVIORAL).
Who is sponsoring clinical trial NCT02416011?
This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02416011's enrollment target sits among peer trials
2,896 43rd of 2000 higher than 1,958 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06273436 · 2,894 participants · NA
Healing, Equity, Advocacy and Respect for Mamas
- NCT05564377 · 2,900 participants · Phase 2
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- NCT07222995 · 2,900 participants · NA
Hybrid Effectiveness-Implementation Trial to Integrate Precision Skin Cancer Risk Feedback in FQHCs
- NCT05624450 · 2,870 participants · Phase 3
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI